Skip to main content
HR 847 108th Congress House

Preserving Access to Safe Affordable Canadian Medicines Act of 2003

Official title: To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs from Canada.

Introduced: February 27, 2003 Introduced by: Sanders, Bernard Independent · Vermont See on congress.gov
Health Access to health careAdministrative procedureCanadaCivil Rights and Liberties, Minority Issues
More subjectsShow fewer subjects
CommerceConsumer protectionContractsDepartment of Health and Human ServicesDiscrimination in medical careDrug industryDrugsFines (Penalties)Foreign Trade and International FinanceGovernment Operations and PoliticsImportsLawPharmaciesPrescription pricing
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 26, 2003
Referred to the Subcommittee on Health.
Feb 13, 2003
Referred to the House Committee on Energy and Commerce.
Feb 13, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 26, 2003

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Preserving Access to Safe, Affordable Canadian Medicines Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations prohibiting discrimination against imports of prescription medications from Canada. Defines discrimination as any measure which has the effect of providing U.S. consumers access to prescription medications on terms or conditions that are less favorable than the terms or conditions provided to any foreign purchaser of such products, or which otherwise restricts or reduces access by United States consumers to a prescription medication from Canadian pharmacies. Imposes a civil penalty against manufacturers who violate this Act.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 14
All 14 Democratic 14
D
McCollum, Betty
Minnesota · Mar 2, 2004
 D
Lynch, Stephen F.
Massachusetts · Jun 16, 2003
 D
Davis, Danny K.
Illinois · Mar 13, 2003
 D
Schakowsky, Janice D.
Illinois · Mar 11, 2003
 D
Norton, Eleanor Holmes
District of Columbia · Feb 27, 2003
 D
Case, Ed
Hawaii · Feb 26, 2003
 D
Baldwin, Tammy
Wisconsin · Feb 13, 2003
 D
DeLauro, Rosa L.
Connecticut · Feb 13, 2003
 D
Doggett, Lloyd
Texas · Feb 13, 2003
 D
Kaptur, Marcy
Ohio · Feb 13, 2003
 D
McGovern, James P.
Massachusetts · Feb 13, 2003
 D
Nadler, Jerrold
New York · Feb 13, 2003
 D
Pallone, Frank
New Jersey · Feb 13, 2003
 D
Velázquez, Nydia M.
New York · Feb 13, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 847: Preserving Access to Safe Affordable Canadian Medicines Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-HR-847/
MLA
"H.R. 847: Preserving Access to Safe Affordable Canadian Medicines Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-847/.
Bluebook (legal)
H.R. 847, 108th Cong. (2026), https://openamerica.io/bill/108-HR-847/.
Markdown link
[H.R. 847: Preserving Access to Safe Affordable Canadian Medicines Act of 2003](https://openamerica.io/bill/108-HR-847/)
Report a problem